Johann Bauersachs

Research interests

Publications

• Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2407107

• 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad195

• Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies

  European Heart Journal · 2022 · 10.1093/eurheartj/ehac223

• 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

  Revista Española de Cardiología (English Edition) · 2022 · 10.1016/j.rec.2022.05.006

• Patient Profiling in Heart Failure for Tailoring Medical Therapy. A Consensus Document of the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2206

• 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

  EP Europace · 2021 · https://doi.org/10.1093/europace/euab232

• 2021 ESC/EACTS Guidelines for the management of valvular heart disease

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab395

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

• Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

  European Journal of Heart Failure · 2020 · https://doi.org/10.1002/ejhf.2029

• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  European Heart Journal · 2020 · https://doi.org/10.1093/eurheartj/ehaa575

• Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

  European Journal of Heart Failure · 2020 · 10.1002/ejhf.1920

• Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

  European Heart Journal · 2020 · 10.1093/eurheartj/ehaa736

• Self-Care of Heart Failure Patients: Practical Management Recommendations from the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2020 · 10.1002/ejhf.2008

• Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2020 · 10.1002/ejhf.1922

• Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2019 · 10.1002/ejhf.1531

• 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz405

• Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2019 · https://doi.org/10.1002/ejhf.1461

• Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

  The Lancet · 2018 · 10.1016/s0140-6736(18)31880-4

• Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology

  European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy596

• Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2018 · 10.1002/ejhf.1170

• 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

  European Heart Journal · 2018 · 10.1093/eurheartj/ehy340

• Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2018 · 10.1002/ejhf.1236

• Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy

  European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehw086

• Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

  New England Journal of Medicine · 2015 · 10.1056/nejmoa1406761

• Cardiac angiogenic imbalance leads to peripartum cardiomyopathy

  Nature · 2012 · 10.1038/nature11040

• The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy

  Nature Communications · 2012 · 10.1038/ncomms2090

• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

  Nature · 2008 · 10.1038/nature07511

• MicroRNAs in the Human Heart

  Circulation · 2007 · 10.1161/circulationaha.107.687947

Current projects

No projects listed.